Are there Biomarkers for Pro Inflammatory Cytokines in Cancer?
Identifying biomarkers for pro inflammatory cytokines can aid in the diagnosis, prognosis, and treatment of cancer. Elevated levels of C-reactive protein (CRP), a marker of inflammation, are often associated with higher levels of pro inflammatory cytokines and worse outcomes in cancer patients. Other potential biomarkers include serum levels of IL-6, IL-1, and TNF, which can help in monitoring disease progression and response to therapy.
